Skip to content

Reported July 17, 2025 · After market close

Revenue$17.2M
EPS-$1.05

Next report

Sep 10, 2026 (in a month)
Revenue estimate$29.0M
EPS estimate-$0.61

Financials

Q4 2025

Income statement

See full
Revenue$17.2M+148%
Gross profit$7.6M+8,334%
Operating income-$48.2M-127%
Net income-$52.1M-121%
EPS (diluted)-$1.57-23.9%

Balance sheet

See full
Cash & equivalents$237.6M+2,780%
Total debt$44.3M-1.9%
Total assets$295.7M+544%

Cash flow

See full
Operating cash flow-$24.1M-33.2%
CapEx$7.4M+142%
Free cash flow-$31.4M-48.9%

Valuation & ratios

Profitability

See full
Gross margin40.5%+39.2pp
Operating margin-177.8%-52.5pp
Net margin-190.3%-57.9pp
FCF margin-168.1%-51.9pp

Returns & leverage

See full
Current ratio6.7×+6.3×

Versus estimates

Ask the moment Kestra Medical Technologies, Ltd. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kestra Medical Technologies, Ltd. report Q4 2025 earnings?
Kestra Medical Technologies, Ltd. (KMTS) reported Q4 2025 earnings on July 17, 2025 after market close.
What were Kestra Medical Technologies, Ltd.'s Q4 2025 revenue and EPS?
Kestra Medical Technologies, Ltd. reported revenue of $17.2M and eps of $-1.05 for Q4 2025.
How did Kestra Medical Technologies, Ltd.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 71.4% from $10.1M a year earlier and eps declined 133.6% from $-0.45.
Where can I find Kestra Medical Technologies, Ltd.'s Q4 2025 SEC filings?
You can read the 10-K periodic report (0000950170-25-096609) directly on SEC EDGAR. The filing index links above go to sec.gov.